Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-12-03

FDA Approved: MIRTAZAPINE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

The FDA approved a supplemental application for Apotex Corp. to market a generic formulation of mirtazapine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

SUPPL AP for MIRTAZAPINE (MIRTAZAPINE)